Emyria

Perth, Australia

Emria is a data-backed drug development and care delivery company.

$2.5M raised

May 2023

Post-IPO Equity

Top Investors

30,000+ verified contacts

Emails, phones & LinkedIn profiles

How much funding has Emyria raised?

Emyria has raised $2.5M in total funding. The most recent round was Post-IPO Equity. The last funding was announced in May 2023.

Who are Emyria's investors?

Emyria's investors include Tattarang, Tenmile, 62 Capital, Taylor Collison Ltd.

Where is Emyria headquartered?

Emyria is headquartered in Perth, Australia.

What does Emyria do?

Emria is a data-backed drug development and care delivery company.

What stage is Emyria at?

Emyria is at the Post-IPO Equity stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated May 1, 2023.

MLA

"Emyria — Funding & Investors." VCBacked, May 1, 2023, https://www.vcbacked.co/company/emyria. Accessed July 2, 2026.

APA

VCBacked. (2023). Emyria — Funding & Investors. Retrieved July 2, 2026, from https://www.vcbacked.co/company/emyria

Wikipedia (cite web)

{{cite web |title=Emyria — Funding & Investors |url=https://www.vcbacked.co/company/emyria |website=VCBacked |access-date=July 2, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated May 1, 2023.